Systemic Lupus Erythematosus

Background: SLE is an autoimmune disease in which the immune system mistakenly attacks healthy tissue in many parts of the body. The most disease onset is between 20-40 years of age with a higher incidence in females.

Model: Pristane induced SLE

Standard study duration: 6 months.

Clinical endpoint: CBC, ANA, Erythema, Urine routine…

Features: Progressive disease development, multiple complications, secondary diseases…

Status: Open for Co-development


For more information about these models, please contact Mr. James Song, mailto:james.song@prisysbiotech.com
TOP